Pharvaris NV (Pharvaris NV) Price-to-Tangible-Book : 2.31 (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV Price-to-Tangible-Book?

As of today (2024-06-05), Pharvaris NV's share price is $16.77. Pharvaris NV's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $7.25. Hence, Pharvaris NV's Price to Tangible Book Ratio of today is 2.31.

The historical rank and industry rank for Pharvaris NV's Price-to-Tangible-Book or its related term are showing as below:

PHVS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.41 Med: 2.86 Max: 5.23
Current: 2.31

During the past 7 years, Pharvaris NV's highest Price to Tangible Book Ratio was 5.23. The lowest was 1.41. And the median was 2.86.

PHVS's Price-to-Tangible-Book is ranked better than
56.67% of 1221 companies
in the Biotechnology industry
Industry Median: 2.81 vs PHVS: 2.31

A closely related ratio is called PB Ratio. As of today, Pharvaris NV's share price is $16.77. Pharvaris NV's Book Value per Sharefor the quarter that ended in Mar. 2024 was $7.25. Hence, Pharvaris NV's P/B Ratio of today is 2.31.

Pharvaris NV Price-to-Tangible-Book Historical Data

The historical data trend for Pharvaris NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV Price-to-Tangible-Book Chart

Pharvaris NV Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.06

2.41

3.50

Pharvaris NV Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.97	3.28	5.23	3.50	3.19

Competitive Comparison of Pharvaris NV's Price-to-Tangible-Book

For the Biotechnology subindustry, Pharvaris NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharvaris NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharvaris NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Pharvaris NV's Price-to-Tangible-Book falls into.

Pharvaris NV Price-to-Tangible-Book Calculation

Pharvaris NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	16.77	/	7.254
	=	2.31

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Pharvaris NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharvaris NV (Pharvaris NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

9EN:Germany

Address

Emmy Noetherweg 2, Leiden, NLD, 2333 BK

Website

https://www.pharvaris.com

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.